TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.94
+0.09 (0.12%)
At close: May 22, 2026, 4:00 PM EDT
68.46
-0.48 (-0.69%)
After-hours: May 22, 2026, 7:57 PM EDT
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 28, 2019 | Dec '18 Dec 29, 2018 | Dec '17 Dec 30, 2017 | Dec '16 Dec 31, 2016 |
|---|
United States Lung Revenue | 12.00M | 13.44M | 15.76M | | | | | | | | |
United States Lung Revenue Growth | -10.70% | -14.67% | 49.36% | | | | | | | | |
United States Heart Revenue | 111.43M | 111.84M | 96.66M | | | | | | | | |
United States Heart Revenue Growth | -0.37% | 15.70% | 63.61% | | | | | | | | |
United States Liver Revenue | 489.67M | 459.42M | 309.46M | | | | | | | | |
United States Liver Revenue Growth | 6.59% | 48.46% | 103.97% | | | | | | | | |
United States OCS Transplant Revenue | 613.10M | 584.70M | 421.88M | | | | | | | | |
United States OCS Transplant Revenue Growth | 4.86% | 38.59% | 90.60% | | | | | | | | |
All Other Countries Lung Revenue | 1.67M | 1.42M | 1.93M | | | | | | | | |
All Other Countries Lung Revenue Growth | 17.77% | -26.38% | 51.41% | | | | | | | | |
All Other Countries Heart Revenue | 15.63M | 14.17M | 13.20M | | | | | | | | |
All Other Countries Heart Revenue Growth | 10.31% | 7.36% | -5.81% | | | | | | | | |
All Other Countries Liver Revenue | 983.00K | 1.11M | 158.00K | | | | | | | | |
All Other Countries Liver Revenue Growth | -11.68% | 604.43% | 51.92% | | | | | | | | |
All Other Countries OCS Transplant Revenue | 18.28M | 16.70M | 15.28M | | | | | | | | |
All Other Countries OCS Transplant Revenue Growth | 9.48% | 9.28% | -0.69% | | | | | | | | |
Total OCS Transplant Revenue | 631.39M | 601.40M | 437.16M | | | | | | | | |
Total OCS Transplant Revenue Growth | 4.99% | 37.57% | 84.66% | | | | | | | | |
| 4.50M | 4.10M | 4.38M | | | | | | | | |
Other Service Revenue Growth | 9.91% | -6.42% | -10.43% | | | | | | | | |
| 635.89M | 605.49M | 441.54M | | | | | | | | |
| 5.02% | 37.13% | 82.74% | | | | | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 28, 2019 | Dec '18 Dec 29, 2018 | Dec '17 Dec 30, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 392.14M | 372.40M | 273.87M | | | | | | | | |
Net Product Revenue Growth | 5.30% | 35.98% | 55.55% | | | | | | | | |
| 243.75M | 233.09M | 167.67M | | | | | | | | |
| 4.57% | 39.02% | 155.78% | | | | | | | | |
| 635.89M | 605.49M | 441.54M | | | | | | | | |
| 5.02% | 37.13% | 82.74% | | | | | | | | |
Updated May 5, 2026. Data Source:
Fiscal.ai.
